Hubid, Mary Jane B.

HRN: 06-69-43  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2024
MUPIROCIN 2%, 15G (TUBE)
04/25/2024
05/02/2024
TOPICAL
Apply On Affected Area
BID
SP Repeat CS W IUD
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: